InvestorNewsBreaks – AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Receive First Payment on ‘Milestone’ Purchase of Cancer Detection Equipment
AnPac Bio-Medical Science (NASDAQ: ANPC), a company with operations in the United States and China focused on early cancer screening and detection, received the first payment in late February 2023 from a Malaysian customer that had purchased AnPac Bio’s Model AP9080 cancer detection devices. The contract for these devices totaled $1.5 million. According to the announcement, the proprietary Model AP9080 features ANPC’s Cancer Differentiation Analysis Technology (“CDA”), a patented, novel multicancer…